Form 4 for ALT Altimmune, Inc.
Accepted 2024-08-01 00:00:00 ET · period of report 2024-07-31 · accession 0001104659-24-084991 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-01 | 2024-07-31 | ALT | Harris Matthew Scott | Chief Medical Off | A - Grant | $5.41 | +1,486 | 55.1K | +3% | +$8,039 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2024-07-31 | A | A | 1,486 | $5.41 | 55,119 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2024. |